Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction.

about

Lipoprotein-Associated Phospholipase A2 is Linked with Poor Cardio-Metabolic Profile in Patients with Ischemic Stroke: A Study of Effects of Statins

P2860

Q57057962-C65E5DDA-55C4-4680-AE5E-0FA21E73603A

P2860

Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction.

Item

http://www.wikidata.org/entity/Q47103077

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparison of the effect of ro ...... h acute myocardial infarction.

@en

Comparison of the effect of ro ...... h acute myocardial infarction.

@nl

type

Item

label

Comparison of the effect of ro ...... h acute myocardial infarction.

@en

Comparison of the effect of ro ...... h acute myocardial infarction.

@nl

prefLabel

Comparison of the effect of ro ...... h acute myocardial infarction.

@en

Comparison of the effect of ro ...... h acute myocardial infarction.

@nl

P1476

Comparison of the effect of ro ...... h acute myocardial infarction.

@en

P2093

Hao Zhu

http://www.w3.org/2001/XMLSchema#string

Nailiang Tian

http://www.w3.org/2001/XMLSchema#string

Yali Gao

http://www.w3.org/2001/XMLSchema#string

Yizhi Ren

http://www.w3.org/2001/XMLSchema#string

Zhongguo Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

The effect of statin therapy on lipoprotein associated phospholipase A2 levels

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

The pathogenesis of atherosclerosis: a perspective for the 1990s

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target.

P304

4942-4950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.5175

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29201198

http://www.w3.org/2001/XMLSchema#string

P932

5704334

http://www.w3.org/2001/XMLSchema#string

Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction.

about

P2860

P2860

Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932